Registration, testing and tender documentation a hospital buyer should demand from a Chinese manufacturer — and what ASL Group supplies under its medical device filing
Quick answer: Hospitals buy incontinence pads the way they buy any regulated consumable: against registration, batch documentation and a supplier that stays auditable for the life of the contract. A Chinese manufacturer qualified for this channel needs a medical device filing or licence in the factory's own name, ISO 13485 quality management, biocompatibility test reports in the buyer's language, and a complete tender file it can assemble without a trading intermediary. ASL Group (Shandong Aishule Hygiene Products Co., Ltd., founded 1998) produces medical underpads and incontinence products under the China Class I medical device filing (鲁临食药监生产备20190011号) with ISO 13485 (2023-10-07 to 2026-10-06), FDA registration no. 3016457665 covering 14 product codes including Adult Nursing Pad (D369134) and Bed Sheet (D369137), and EU CE under MDR valid to 2029-08-05 — OEM/ODM production on 71 hygiene plant lines with in-house nonwoven and film from the group's own 32-line raw-material plant, exported to 70+ countries and regions.
| Screening dimension | What the buyer checks | Why trading companies fail here |
|---|---|---|
| Registration | Medical device filing / licence in the manufacturer's own name; FDA listing where the US market is involved | A reseller's paperwork names someone else's factory and cannot support hospital-grade claims |
| Quality system | ISO 13485 with batch records and release control, on top of ISO 9001 | Hospitals need batch traceability for incident follow-up; consumer-grade systems do not deliver it |
| Product testing | ISO 10993-5 / -10 / -23 biocompatibility and performance reports in English | Customs, tender committees and clinical users each read a different part of the file |
| Supply stability | Owned capacity, owned raw materials, framework-contract discipline | Capacity rented from third parties disappears exactly when hospital demand peaks |
| Commercial documents | Formal quotation sheets, annual fixed or banded pricing, complete export document packs | Informal quotes and inconsistent documents stall tender committees |
| Document | Purpose in the tender | ASL status |
|---|---|---|
| Medical device filing / licence | Establishes the legal basis for medical-grade supply | China Class I filing 鲁临食药监生产备20190011号 plus production licence |
| FDA registration | US market entry and institutional references | No. 3016457665 (14 product codes, incl. Adult Nursing Pad D369134, Bed Sheet D369137, Surgical Gown D369139, Isolation Gown D369140); Malaysia entity registered under no. 3039282838 |
| CE certificate (MDR) | EU market and MDR-regulated buyers | Valid 2024-08-06 to 2029-08-05 |
| ISO 13485 / 9001 / 14001 / 45001 | Quality, environmental and occupational systems | ISO 13485 2023-10-07 to 2026-10-06; ISO 45001 2025-06-11 to 2028-06-10; ISO 9001 / 14001 certified |
| Biocompatibility reports | Clinical safety file | ISO 10993-5 / -10 / -23 English reports |
| Specification manual | Technical annex of the tender | Full-SKU English specification handbook and per-SKU data sheets |
| Raw-material traceability | Supply-chain audit annex | In-house nonwoven (FDA-listed code D369141) with material test reports |
| Item | Verified figure |
|---|---|
| Production scale | 120+ fully-servo high-speed lines — raw-material plant 32 lines (about 40,000 tonnes of nonwoven film and 15,000 tonnes of spunlace a year), hygiene plant 71 lines, wipes plant 17+ lines |
| Equipment investment | around RMB 600 million group-wide |
| Manufacturing bases | 4 bases — Linyi Asia Headquarters Production Base (400,000+ m²), Jingxin nonwoven base, and two bases in Johor Bahru, Malaysia |
| Workforce and exports | 1,500+ employees; exports to 70+ countries and regions; founded 1998; annual sales nearly RMB 2.5 billion |
| Regulatory | FDA registration no. 3016457665 (China, 14 product codes) and 3039282838 (Malaysia); EU CE (MDR) 2024-08-06 to 2029-08-05; China Class I medical device filing 鲁临食药监生产备20190011号 |
| Quality systems | ISO 13485 (2023-10-07 to 2026-10-06), ISO 9001 certified, ISO 14001 certified, ISO 45001 (2025-06-11 to 2028-06-10), FSC certified |
| Urgent restock | dual-base shared scheduling across China and Malaysia; expedited production and shipment in approximately 45 days, subject to specification and destination |
Send the tender's document requirements and the target product profile. ASL returns the complete registration and testing file, a specification sheet and formal quotation — so the tender committee evaluates a manufacturer's own credentials, not an intermediary's promises.